The effect of HIT on walking speed and walking endurance

Author (year)GroupConditionGait speed6-minute walk test
Walking speed pre/post (m/s)Mean difference (m/s)P-valueWalking speed at follow-up (m/s)Walking endurance pre/post (m)Mean difference (m)P-valueWalking endurance at follow-up (m)
Outermans et al. (2010) [26]CSS1.4 ± 0.5/1.4 ± 0.400.03None401 ± 132/422 ± 128210.02No follow-up
ESS1.5 ± 0.5/1.7 ± 0.50.2459 ± 146/519 ± 16560
MacKay-Lyons et al. (2013) [27]CSS0.56 ± 0.19/0.71 ± 0.200.15None6 months = 0.73 ± 0.20
12 months = 0.74 ± 0.17
195 ± 78/232 ± 8037None6 months = 239 ± 89
12 months = 242 ± 81
ESS0.52 ± 0.21/0.75 ± 0.220.236 months = 0.76 ± 0.19 12months = 0.78 ± 0.22189 ± 82/279 ± 89906 months = 282 ± 99
12 months = 287 ± 88
Holleran et al. (2014) [23]ESS0.33 ± 0.27/0.66 ± 0.350.33N/A3 months = 0.65 ± 0.36119 ± 94/263 ± 170144N/A3 months = 260 ± 169
FS0.47 ± 0.41/1.00 ± 0.670.533 months = 0.95 ± 0.62
Leddy et al., (2016) [30]CSS0.47 ± 0.28/0.58 ± 0.250.11None2–3 months = 0.63 ± 0.29Not collected
ESS0.35 ± 0.18/0.76 ± 0.360.392–3 months = 0.78 ± 0.38
Hornby et al. (2016) [28]CSS0.35 ± 0.24/0.43 ± 0.270.08< 0.052 months = 0.47 ± 0.35131 ± 108/160 ± 11129< 0.052 months = 169 ± 121
ESS0.32 ± 0.25/0.59 ± 0.370.272 months = 0.65 ± 0.42116 ± 88/232 ± 1491162 months = 227 ± 160
CFS0.46 ± 0.35/0.57 ± 0.430.11None2 months = 0.60 ± 0.43N/A
EFS0.48 ± 0.37/0.84 ± 0.600.362 months = 0.85 ± 062
Mahtani et al. (2017) [41]CSS0.62 ± 0.31/0.75 ± 0.330.13< 0.01NoneNot collected
ESS0.54 ± 0.32/1.00 ± 0.470.56
Moore et al. (2020) [24]CSS0.62 ± 0.34/0.79 ± 0.340.17< 0.001None243 ± 138/303 ± 13060< 0.001No follow-up
ESS0.64 ± 0.33/1.00 ± 0.400.36243 ± 141/378 ± 156135
CFS0.85 ± 0.49/1.00 ± 0.490.15< 0.001NoneN/A
EFS0.89 ± 0.49/1.37 ± 0.520.48
Henderson et al. (2022) [25]E-LoA > 5SS0.08 (0–0.23)/0.63 (0.38–0.95)0.55N/ANone16 (6–44)/213 (117–317)197N/ANo follow-up
Klassen et al. (2020) [29]CSS0.39 ± 0.22/0.74 ± 0.370.35None6 months = 1.0 ± 0.50
12 months = 1.07 ± 0.60
129 ± 77.6/246 ± 1381370.026 months = 328 ± 144
12 months = 351 ± 180
E -DOSE1SS0.44 ± 0.25/0.90 ± 0.310.466 months = 1.02 ± 0.24
12 months = 1.04 ± 0.23
129 ± 97.3/307 ± 1181786 months = 358 ± 125
12 months = 401 ± 146
CSS0.39 ± 0.22/0.74 ± 0.370.35None6 months = 1.0 ± 0.50
12 months = 1.07 ± 0.60
129 ± 77.6/246 ± 1381370.036 months = 328 ± 144
12 months = 351 ± 180
E-DOSE2SS0.42 ± 0.25/0.97 ± 0.400.556 months = 1.02 ± 0.44
12 months = 1.11 ± 0.43
138 ± 95.5/315 ± 1421776 months = 355 ± 149
12 months = 375 ± 147
Brauer et al. (2021) [40]ESS0.72 ± 0.29/0.99 ± 0.360.27N/A26 weeks = 1.01 ± 0.33277 ± 142/368 ± 14491N/A26 weeks = 402 ± 141

C: control group; SS: self-select speed; E: experimental group; None: not reported; N/A: does not apply; FS: fastest speed; LoA: level of assistance; DOSE: determining optimal poststroke exercise. Variability is noted as standard deviation or range